Sulfametrole

DB15975

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 286.32
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

109 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfametrole is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfametrole is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfametrole is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfametrole is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfametrole is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfametrole is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfametrole.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfametrole.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfametrole.
Cyclosporine The risk or severity of renal failure can be increased when Sulfametrole is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfametrole.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfametrole.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfametrole.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfametrole.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfametrole.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfametrole.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfametrole.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfametrole.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfametrole.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfametrole.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfametrole.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfametrole.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfametrole.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfametrole.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfametrole.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfametrole.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfametrole.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfametrole.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfametrole.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfametrole.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfametrole.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfametrole.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfametrole.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfametrole.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfametrole.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfametrole.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfametrole.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfametrole.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfametrole.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfametrole.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfametrole.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfametrole.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfametrole.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfametrole.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfametrole.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfametrole.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfametrole.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfametrole.
NN344 The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfametrole.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfametrole.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfametrole.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfametrole.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfametrole.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfametrole.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfametrole.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfametrole.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfametrole.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfametrole.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfametrole.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfametrole.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfametrole.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfametrole.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfametrole.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfametrole.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfametrole.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfametrole.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfametrole.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfametrole is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfametrole.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfametrole.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfametrole.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfametrole.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfametrole.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfametrole.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfametrole.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfametrole.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfametrole.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfametrole.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfametrole.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfametrole.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfametrole.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfametrole.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfametrole.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfametrole.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfametrole.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfametrole.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfametrole.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfametrole.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfametrole.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul